SanBio: Notice Regarding Completion of Approval Filing for Japan SB623 Chronic TBI Program
TOKYO & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SanBio completed the application filing with Japan’s MHLW for manufacture and marketing approval as a regenerative medicine product.
